Article Type
Changed
Wed, 06/19/2019 - 13:35
Display Headline
Clinical pearls from NAMS 2017

Visit the NAMS annual meetings website

Share your thoughts! Send your Letter to the Editor to rbarbieri@frontlinemedcom.com. Please include your name and the city and state in which you practice.

Author and Disclosure Information

Dr. Kaunitz is University of Florida Term Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine-Jacksonville. He is Medical Director and Director of Menopause and Gynecologic Ultrasound Services at UF Women's Health Specialists-Emerson. He also serves on the OBG Management Board of Editors.

Dr. Kaunitz reports that he serves as a consultant to Allergan, AMAG, Bayer HealthCare Pharmaceuticals, Pfizer, Sebela, and Shionogi. He receives research grants (funds paid to the University of Florida) from Allergan, Bayer HealthCare Pharmaceuticals, Endoceutics, Millendo, and TherapeuticsMD, and he receives royalties from UpToDate.

Issue
OBG Management - 29(10)
Publications
Topics
Sections
Author and Disclosure Information

Dr. Kaunitz is University of Florida Term Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine-Jacksonville. He is Medical Director and Director of Menopause and Gynecologic Ultrasound Services at UF Women's Health Specialists-Emerson. He also serves on the OBG Management Board of Editors.

Dr. Kaunitz reports that he serves as a consultant to Allergan, AMAG, Bayer HealthCare Pharmaceuticals, Pfizer, Sebela, and Shionogi. He receives research grants (funds paid to the University of Florida) from Allergan, Bayer HealthCare Pharmaceuticals, Endoceutics, Millendo, and TherapeuticsMD, and he receives royalties from UpToDate.

Author and Disclosure Information

Dr. Kaunitz is University of Florida Term Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine-Jacksonville. He is Medical Director and Director of Menopause and Gynecologic Ultrasound Services at UF Women's Health Specialists-Emerson. He also serves on the OBG Management Board of Editors.

Dr. Kaunitz reports that he serves as a consultant to Allergan, AMAG, Bayer HealthCare Pharmaceuticals, Pfizer, Sebela, and Shionogi. He receives research grants (funds paid to the University of Florida) from Allergan, Bayer HealthCare Pharmaceuticals, Endoceutics, Millendo, and TherapeuticsMD, and he receives royalties from UpToDate.

Related Articles

Visit the NAMS annual meetings website

Share your thoughts! Send your Letter to the Editor to rbarbieri@frontlinemedcom.com. Please include your name and the city and state in which you practice.

Visit the NAMS annual meetings website

Share your thoughts! Send your Letter to the Editor to rbarbieri@frontlinemedcom.com. Please include your name and the city and state in which you practice.

Issue
OBG Management - 29(10)
Issue
OBG Management - 29(10)
Publications
Publications
Topics
Article Type
Display Headline
Clinical pearls from NAMS 2017
Display Headline
Clinical pearls from NAMS 2017
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.